These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36174721)
1. Serum biomarkers for liver fibrosis. Chen Z; Ma Y; Cai J; Sun M; Zeng L; Wu F; Zhang Y; Hu M Clin Chim Acta; 2022 Dec; 537():16-25. PubMed ID: 36174721 [TBL] [Abstract][Full Text] [Related]
2. Advances in the clinical use of collagen as biomarker of liver fibrosis. Meurer SK; Karsdal MA; Weiskirchen R Expert Rev Mol Diagn; 2020 Sep; 20(9):947-969. PubMed ID: 32865433 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Gressner OA; Weiskirchen R; Gressner AM Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697 [TBL] [Abstract][Full Text] [Related]
4. Hepatic fibrosis and its serum markers: a review. Gabrielli GB; Corrocher R Dig Dis; 1991; 9(5):303-16. PubMed ID: 1752069 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive diagnosis of advanced fibrosis and cirrhosis. Sharma S; Khalili K; Nguyen GC World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996 [TBL] [Abstract][Full Text] [Related]
6. Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases. Vozar I Bratisl Lek Listy; 2005; 106(3):123-6. PubMed ID: 16026147 [TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis markers in alcoholic liver disease. Chrostek L; Panasiuk A World J Gastroenterol; 2014 Jul; 20(25):8018-23. PubMed ID: 25009372 [TBL] [Abstract][Full Text] [Related]
8. New diagnostic method for liver fibrosis and cirrhosis. Han KH; Yoon KT Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943 [TBL] [Abstract][Full Text] [Related]
9. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology. Yilmaz Y; Eren F Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):43-46. PubMed ID: 30134384 [TBL] [Abstract][Full Text] [Related]
10. Hepatic fibrosis: are any of the serum markers useful? Oh S; Afdhal NH Curr Gastroenterol Rep; 2001 Feb; 3(1):12-8. PubMed ID: 11177689 [TBL] [Abstract][Full Text] [Related]
11. Circulating markers of liver fibrosis progression. Jarcuska P; Janicko M; Veselíny E; Jarcuska P; Skladaný L Clin Chim Acta; 2010 Aug; 411(15-16):1009-17. PubMed ID: 20399764 [TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C and liver fibrosis. Sebastiani G; Gkouvatsos K; Pantopoulos K World J Gastroenterol; 2014 Aug; 20(32):11033-53. PubMed ID: 25170193 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of liver fibrosis: key messages for clinicians. Caviglia GP; Touscoz GA; Smedile A; Pellicano R Pol Arch Med Wewn; 2014; 124(6):329-35. PubMed ID: 24781707 [TBL] [Abstract][Full Text] [Related]
14. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. Gressner AM; Gao CF; Gressner OA World J Gastroenterol; 2009 May; 15(20):2433-40. PubMed ID: 19468990 [TBL] [Abstract][Full Text] [Related]
15. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Zehra M; Curry JC; Pillai SS; Lakhani HV; Edwards CE; Sodhi K Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635162 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive diagnosis of liver fibrosis and cirrhosis. Lurie Y; Webb M; Cytter-Kuint R; Shteingart S; Lederkremer GZ World J Gastroenterol; 2015 Nov; 21(41):11567-83. PubMed ID: 26556987 [TBL] [Abstract][Full Text] [Related]